We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Fully Automated FIT Analyzer Designed for Labs with High Fecal Testing Volumes

By LabMedica International staff writers
Posted on 16 Jun 2022
Print article
Image: New SENTiFIT 800 analyzer for fecal immunochemical testing (Photo courtesy of Sentinel Diagnostics)
Image: New SENTiFIT 800 analyzer for fecal immunochemical testing (Photo courtesy of Sentinel Diagnostics)

Colorectal Cancer (CRC) is one of the most dangerous and lethal cancers. It represents the second leading cause of cancer related death in the western world with almost two million of new cases/year and 0.9 million deaths. If early diagnosed, CRC is curable in most of the cases, therefore most countries organize national or regional screenings to identify the cancers in their early stage, making the cure more efficient and thus considerably decreasing mortality. Those screening programs are testing millions of people every year and this creates new challenges in the practical organization of the laboratories. Now, a new high throughput analyzer for fecal immunochemical testing can meet the need for throughput, automation and accuracy in the most demanding situations.

Sentinel Diagnostics’ (Milan, Italy) new SENTiFIT 800 analyzer is a fully automated and high throughput system for fecal immunochemical test. The high-end system dedicated to fecal testing is able to process up to 550 tests per hour and one million tests every year with total automation and full traceability. It enables a reduction in hands-on time, better management of resources and decrease in manual errors. The system is fed by a dedicated sample loader (Rack Handler RH-150) that provides a steady flow of up to 250 samples to the analyzer unit.

The CE-marked SENTiFIT 800 Analyzer is compatible with the company’s FOB Gold line, the complete solution for the identification of occult blood in feces, and with its CALiaGold line of reagents for the quantification of fecal Calprotectin, the first-choice test to identify the presence of inflammation in the bowel.

"For almost 20 years, Sentinel Diagnostics has supported the fight against colorectal cancer with high quality FOB Gold test and analyzers," said Marco Buonaguidi, Head of Sales and Marketing at Sentinel Diagnostics. "The SENTiFIT 800 has been developed specifically for FIT screening centers and represents a step further in the direction to strengthen our commitment in the field of gastrointestinal diseases diagnosis."

Related Links:
Sentinel Diagnostics 

New
Gold Supplier
Real-Time PCR System
STC-96A Plus
New
HBV Test
ELISA HBV Test Kit
New
Automated Hematology Workstation
XN-3000
New
Portable Molecular Workstation
iPonatic III

Print article
IIR Middle East

Channels

Technology

view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more

Industry

view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.